HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cellular and extracellular miRNAs are blood-compartment-specific diagnostic targets in sepsis.

Abstract
Septic shock is a common medical condition with a mortality approaching 50% where early diagnosis and treatment are of particular importance for patient survival. Novel biomarkers that serve as prompt indicators of sepsis are urgently needed. High-throughput technologies assessing circulating microRNAs represent an important tool for biomarker identification, but the blood-compartment specificity of these miRNAs has not yet been investigated. We characterized miRNA profiles from serum exosomes, total serum and blood cells (leukocytes, erythrocytes, platelets) of sepsis patients by next-generation sequencing and RT-qPCR (n = 3 × 22) and established differences in miRNA expression between blood compartments. In silico analysis was used to identify compartment-specific signalling functions of differentially regulated miRNAs in sepsis-relevant pathways. In septic shock, a total of 77 and 103 miRNAs were down- and up-regulated, respectively. A majority of these regulated miRNAs (14 in serum, 32 in exosomes and 73 in blood cells) had not been previously associated with sepsis. We found a distinctly compartment-specific regulation of miRNAs between sepsis patients and healthy volunteers. Blood cellular miR-199b-5p was identified as a potential early indicator for sepsis and septic shock. miR-125b-5p and miR-26b-5p were uniquely regulated in exosomes and serum, respectively, while one miRNA (miR-27b-3p) was present in all three compartments. The expression of sepsis-associated miRNAs is compartment-specific. Exosome-derived miRNAs contribute significant information regarding sepsis diagnosis and survival prediction and could serve as newly identified targets for the development of novel sepsis biomarkers.
AuthorsMarlene Reithmair, Dominik Buschmann, Melanie Märte, Benedikt Kirchner, Daniel Hagl, Ines Kaufmann, Martina Pfob, Alexander Chouker, Ortrud K Steinlein, Michael W Pfaffl, Gustav Schelling
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 21 Issue 10 Pg. 2403-2411 (10 2017) ISSN: 1582-4934 [Electronic] England
PMID28382754 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Chemical References
  • Biomarkers
  • MicroRNAs
Topics
  • Biomarkers (blood)
  • Blood Platelets (metabolism)
  • Erythrocytes (metabolism)
  • Exosomes (genetics, ultrastructure)
  • Gene Expression Profiling (methods)
  • Humans
  • Leukocytes (metabolism)
  • MicroRNAs (blood, genetics)
  • Microscopy, Electron, Transmission
  • Prognosis
  • Sepsis (blood, diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: